By:DengYue International Business Division Against the backdrop of a profound restructuring of the global innovative drug value chain, China’s pharmaceutical industry is moving toward the center of the international stage at an unprecedented pace. In 2025, the total value of China’s outbound innovative drug licensing (license-out) transactions officially surpassed USD 100 billion,...